Medicare will save approximately $12 billion, or 44%, on 15 high-cost medications as a result of the second round of the program’s drug price negotiations, the Trump administration announced Tuesday ...

The Trump administration negotiated lower prices on 15 costly drugs under Medicare, including Ozempic and Wegovy.

The reduced prices were negotiated through the Medicare Drug Price Negotiation Program created by the Inflation Reduction Act ...

Major stock indexes ended sharply higher Monday to begin a holiday-shortened trading week, with investors increasingly confident the Federal Reserve will cut interest rates at its December meeting.

Patients and doctors are bracing as some major insurers get ready to roll out changes to coverage for popular weight loss drugs in Massachusetts. In January, companies including Blue Cross Blue Shield ...

The lower prices stem from the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

In addition to Ozempic, other drugs that will cost Medicare less thanks to the negotiations include GSK’s Trelegy asthma ...

The US government said it negotiated a 71% discount on Novo Nordisk A/S’s blockbuster Ozempic and Wegovy drugs for patients ...

EST Medicare negotiates 71% discount on Novo’s Ozempic, Wegovy, Bloomberg says Published first on TheFly – the ultimate source for ...

Increasingly, telehealth platforms are positioning blockbuster weight-loss shots not as medicines to treat obesity or diabetes but as cosmetic elixirs for anyone who wants to lose a few pounds.

Medicare will announce negotiated prices for 15 high-cost drugs, impacting over 67 million beneficiaries. The Inflation ...

Novo Nordisk's highly anticipated but ultimately unsuccessful Alzheimer's trials were a long shot for the maker of blockbuster drugs Ozempic and Wegovy, but scientists are still asking if GLP-1 drugs ...